Study aims to personalize cervical cancer treatment
UF researchers aim to determine which of two blood tests can help doctors better track how cervical cancer responds to treatment.
UF researchers aim to determine which of two blood tests can help doctors better track how cervical cancer responds to treatment.
Researchers validated protein biomarkers, putting them one step closer to a point-of-care cervical cancer screening test.
UF Health Cancer Center Rahma Mkuu, Ph.D., discussed the significance of self-collected samples to test for cervical cancer.
The gathering empowered community members by providing information about breast, ovarian and cervical cancers.
The K01 funding is highly competitive for early-career researchers seeking to gain mentored career development experience.
To better serve this population, the mobile mammography unit will feature more than just mammograms.
The one-tube testing method uses CRISPR technology and targets DNA from body fluids.